Rchr
J-GLOBAL ID：202101018596544029   Update date: Oct. 15, 2023

Dobashi Yoh

Dobashi Yoh
Research field  (1)： Medical biochemistry
Research theme for competitive and other funds  (20)：
  • 2020 - 2023 Analysis of aberrant Akt/mTOR signature for the precision medicine in lung carcinoma
  • 2017 - 2022 Dysregulation of AKT network and its application for precision medicine in lung cancer
  • 2015 - 2019 Analysis of AMF and its related proteins in lung cancer
  • 2014 - 2018 Involvement of Akt/mTOR in lung cancer and design of novel therapy targeting them
  • 2011 - 2013 Aberrant activations of cellular kinases and exploration of novel targeted therapy in human solid cancers
Show all
Papers (103)：
  • Kentaro Minegishi, Yoh Dobashi, Teruhide Koyama, Yuko Ishibashi, Miki Furuya, Hiroyoshi Tsubochi, Yasukazu Ohmoto, Tomohiko Yasuda, Sachiyo Nomura. Diagnostic utility of trefoil factor families for the early detection of lung cancer and their correlation with tissue expression. Oncology letters. 2023. 25. 4. 139-139
  • Kentaro Minegishi, Yoh Dobashi, Hiroyoshi Tsubochi, Koichi Hagiwara, Yuko Ishibashi, Sachiyo Nomura, Ritsuko Nakamura, Yasukazu Ohmoto, Shunsuke Endo. TFF-1 Functions to Suppress Multiple Phenotypes Associated with Lung Cancer Progression. OncoTargets and Therapy. 2021. Volume 14. 4761-4777
  • Nakamura, R., Oyama, T., Inokuchi, M., Ishikawa, S., Hirata, M., Kawashima, H., Ikeda, H., Dobashi, Y., Ooi, A. Neural EGFL like 2 expressed in myoepithelial cells and suppressed breast cancer cell migration. Pathology International. 2021. 71. 5
  • Hiroyoshi Tsubochi, Kentaro Minegishi, Akiteru Goto, Ritsuko Nakamura, Daisuke Matsubara, Yoh Dobashi. EphA2, a possible target of miR-200a, functions through the AKT2 pathway in human lung carcinoma. International journal of clinical and experimental pathology. 2020. 13. 8. 2201-2210
  • Nakamura, R., Oyama, T., Inokuchi, M., Ishikawa, S., Hirata, M., Kawashima, H., Ikeda, H., Dobashi, Y., Ooi, A. The relation between anti-TGBFR1 immunohistochemical reaction and low Ki67, small tumor size and high estrogen receptor expression in invasive breast cancer. Pathology International. 2020. 70. 6
ｍore...
MISC (15)：
  • 土橋 洋, 中村 律子, 椙村 春彦, 岡田 真也, 潮見 隆之. 培養細胞におけるTrefoil factor-1の発現、分泌様式とその細胞増殖、浸潤能への関与. 日本病理学会会誌. 2021. 110. 1. 251-251
  • 土橋 洋, 中村 律子, 椙村 春彦, 大井 章史, 山田 茂樹. mTORにより制御されるtrefoil factor-1の発現、転写機序と肺癌における意義. 日本病理学会会誌. 2020. 109. 1. 296-296
  • 土橋 洋, 山田 茂樹, 大井 章史, 中村 律子, 椙村 春彦. mTORにより制御されるtrefoil factor-1と肺癌におけるその意義. 日本病理学会会誌. 2019. 108. 1. 287-287
  • 土橋 洋, 椙村 春彦, 山田 茂樹, 大井 章史. mTORにより制御されるtrefoil factor-1と肺癌におけるその動態. 日本病理学会会誌. 2018. 107. 1. 294-294
  • 土橋 洋, 椙村 春彦, 山田 茂樹, 大井 章史. mTORにより制御されるtrefoil factor-1と肺癌におけるその動態. 日本病理学会会誌. 2018. 107. 1. 294-294
ｍore...
Books (5)：
  • シンプル病理学
    南江堂 2020 ISBN:9784524249343
  • シンプル病理学(改訂第7版)
    南江堂 2015 ISBN:4524261540
  • シンプル病理学
    南江堂 2010 ISBN:9784524260874
  • シンプル病理学第5版
    南江堂 2007 ISBN:9784524243181
  • シンプル病理学 第4版
    南江堂 2004 ISBN:4524235825
Education (1)：
  • 1978 - 1984 Gunma University Faculty of Medicine School of Medicine
Work history (1)：
  • 2021/01 - 現在 International University of Health and Welfare School of Medicine Department of Pathology Professor
Committee career (2)：
  • 1991/04 - 現在 Japanese Society of Pathology Councilor
  • 2012/10 - 2022/03 Japan Cancer Association Councilor
Awards (3)：
  • 2004/05 - Yamanashi Science Academy Yamanashi Science Academy Research Promotion Award Cell cycle control and its aberrations in human cancers.
  • 1998/09 - Mitsui Life Welfare Research Award
  • 1991/09 - The Ichiro Kanehara Foundation The Ichiro Kanehara Foundation for the Promotion of Medical Sciences and Medical Care Mutation of p53 gene in bone and soft tissue tumors
Association Membership(s) (2)：
Japan Cancer Society ,  Japanese Society of Pathology
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page

TOP

BOTTOM